2020
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
Clinical Cancer Research | AACR
Clinical Cancer Research | AACR
Dissecting racial disparities in multiple myeloma
Blood Cancer Journal
Blood Cancer Journal
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Journal of Clinical Oncology
Journal of Clinical Oncology
Prediagnosis dietary pattern and survival in patients with multiple myeloma
International Journal of Cancer
International Journal of Cancer
Bone marrow niches in haematological malignancies
Nature Reviews. Cancer
Nature Reviews. Cancer
The microenvironment in myeloma
Current Opinion in Oncology
Current Opinion in Oncology
Clinical Controversies in the Management of Smoldering Multiple Myeloma
American Society of Clinical Oncology Educational Book | ASCO
American Society of Clinical Oncology Educational Book | ASCO
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Nature Cancer
Nature Cancer
Intensification and consolidation therapy in multiple myeloma in the current era
The Lancet. Haematology
The Lancet. Haematology
The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action
Cancer Epidemiology, Biomarkers, and Prevention | AACR
Cancer Epidemiology, Biomarkers, and Prevention | AACR
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
Blood
Blood
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression
Journal of Clinical Oncology
Journal of Clinical Oncology
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
Nature Communications
Nature Communications
Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All
Cancers (Basel)
Cancers (Basel)
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
Journal of Clinical Oncology
Journal of Clinical Oncology